Company Growth (employees)
Foundation Medicine was founded in 2010 and is headquartered in Cambridge, US
Key People at Foundation Medicine
Michael J. Pellini
President & CEO & Board Director
Steven J. Kafka
Chief Business Officer
Alexis Borisy
Co - Founder & Chairman of the Board
Vincent A. Miller
SVP, Clinical Development
Foundation Medicine Office Locations
Foundation Medicine has an office in Cambridge
Cambridge, US (HQ)
150 Second St
Foundation Medicine Data and Metrics
Foundation Medicine Financial Metrics
Foundation Medicine's revenue was reported to be $116.9 m in FY, 2016 which is a 25% increase from the previous period.
Numbers are in $, USD
Revenue (FY, 2016) | 116.9 m |
Revenue growth (FY, 2015 - FY, 2016), % | 25% |
Gross profit (FY, 2016) | 63.9 m |
Gross profit margin (FY, 2016), % | 55% |
Net income (FY, 2016) | (113.2 m) |
EBIT (FY, 2016) | (113.8 m) |
Market capitalization (26-May-2017) | 1.4 b |
Closing share price (26-May-2017) | 39.5 |
Cash (31-Dec-2016) | 63.6 m |
Foundation Medicine's current market capitalization is $1.4 b.
- Source: SEC Filings
| Numbers are in $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 29 m | 61.1 m | 93.2 m | 116.9 m |
Revenue growth, % | 111% | 53% | 25% | |
Cost of goods sold | 11.7 m | 27.4 m | 36.7 m | 53 m |
Gross profit | 17.3 m | 33.6 m | 56.5 m | 63.9 m |
Gross profit Margin, % | 60% | 55% | 61% | 55% |
Operating expense total | 59.1 m | 86.9 m | 146.3 m | 230.7 m |
EBIT | (41.8 m) | (53.3 m) | (89.8 m) | (113.8 m) |
EBIT margin, % | (144%) | (87%) | (96%) | (97%) |
Interest expense | 235 k | 42 k | 124 k | 624 k |
Net Income | (42.9 m) | (52.2 m) | (89.6 m) | (113.2 m) |
- Source: SEC Filings
| Numbers are in $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 124.3 m | 72.1 m | 117.8 m | 63.6 m |
Accounts Receivable | 6.3 m | 9.9 m | 7.4 m | 8.2 m |
Inventories | 992 k | 2.9 m | 6.5 m | 5.3 m |
Current Assets | 133.3 m | 89.6 m | 229.6 m | 168.9 m |
PP&E | 22.1 m | 21 m | 41.3 m | 41.5 m |
Total Assets | 157.3 m | 111.9 m | 298 m | 214 m |
Accounts Payable | 7 m | 7.3 m | 10.5 m | 11.9 m |
Current Liabilities | 15.8 m | 16.4 m | 29.9 m | 40.7 m |
Additional Paid-in Capital | 221.5 m | 228.2 m | 489.5 m | 509.7 m |
Retained Earnings | (89.8 m) | (142 m) | (231.6 m) | (344.8 m) |
Total Equity | 131.7 m | 86.2 m | 257.7 m | 164.8 m |
Financial Leverage | 1.2 x | 1.3 x | 1.2 x | 1.3 x |
| Numbers are in $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | (42.9 m) | (52.2 m) | (89.6 m) | (113.2 m) |
Depreciation and Amortization | 5 m | 8.2 m | 10.6 m | 15.9 m |
Accounts Receivable | (4.1 m) | (3.6 m) | 2.4 m | (844 k) |
Inventories | (442 k) | (1.9 m) | (3.7 m) | 1.3 m |
Accounts Payable | 1.7 m | 3.1 m | (1.6 m) | 5.1 m |
Cash From Operating Activities | (30.8 m) | (42.7 m) | (63.7 m) | (67.2 m) |
Purchases of PP&E | (6.9 m) | (9.7 m) | (25.4 m) | (20.9 m) |
Cash From Investing Activities | (8.5 m) | (8.8 m) | (140.7 m) | 12.7 m |
Cash From Financing Activities | 108.7 m | (650 k) | 250.1 m | 333 k |
Interest Paid | 171 k | 263 k | 263 k | 77 k |
| Y, 2016 | |
|---|---|
Financial Leverage | 1.3 x |
Foundation Medicine Market Value History
Foundation Medicine Revenue Breakdown
Foundation Medicine Median Salaries
Source: 15 public H-1B filings from Foundation Medicine
